Cargando…

Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance

Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of disorders ranging from simple steatosis (non-alcoholic fatty liver, NAFL) to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFL increases the risk of liver fibrosis. If the liver is fatty due to causes of insulin resistance such as...

Descripción completa

Detalles Bibliográficos
Autor principal: Yki-Järvinen, Hannele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663582/
https://www.ncbi.nlm.nih.gov/pubmed/26556368
http://dx.doi.org/10.3390/nu7115454
_version_ 1782403327747686400
author Yki-Järvinen, Hannele
author_facet Yki-Järvinen, Hannele
author_sort Yki-Järvinen, Hannele
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of disorders ranging from simple steatosis (non-alcoholic fatty liver, NAFL) to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFL increases the risk of liver fibrosis. If the liver is fatty due to causes of insulin resistance such as obesity and physical inactivity, it overproduces glucose and triglycerides leading to hyperinsulinemia and a low high-density lipoprotein (HDL) cholesterol concentration. The latter features predispose to type 2 diabetes and cardiovascular disease (CVD). Understanding the impact of nutritional modulation of liver fat content and insulin resistance is therefore of interest for prevention and treatment of NAFLD. Hypocaloric, especially low carbohydrate ketogenic diets rapidly decrease liver fat content and associated metabolic abnormalities. However, any type of caloric restriction seems effective long-term. Isocaloric diets containing 16%–23% fat and 57%–65% carbohydrate lower liver fat compared to diets with 43%–55% fat and 27%–38% carbohydrate. Diets rich in saturated (SFA) as compared to monounsaturated (MUFA) or polyunsaturated (PUFA) fatty acids appear particularly harmful as they increase both liver fat and insulin resistance. Overfeeding either saturated fat or carbohydrate increases liver fat content. Vitamin E supplementation decreases liver fat content as well as fibrosis but has no effect on features of insulin resistance.
format Online
Article
Text
id pubmed-4663582
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-46635822015-12-10 Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance Yki-Järvinen, Hannele Nutrients Review Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of disorders ranging from simple steatosis (non-alcoholic fatty liver, NAFL) to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFL increases the risk of liver fibrosis. If the liver is fatty due to causes of insulin resistance such as obesity and physical inactivity, it overproduces glucose and triglycerides leading to hyperinsulinemia and a low high-density lipoprotein (HDL) cholesterol concentration. The latter features predispose to type 2 diabetes and cardiovascular disease (CVD). Understanding the impact of nutritional modulation of liver fat content and insulin resistance is therefore of interest for prevention and treatment of NAFLD. Hypocaloric, especially low carbohydrate ketogenic diets rapidly decrease liver fat content and associated metabolic abnormalities. However, any type of caloric restriction seems effective long-term. Isocaloric diets containing 16%–23% fat and 57%–65% carbohydrate lower liver fat compared to diets with 43%–55% fat and 27%–38% carbohydrate. Diets rich in saturated (SFA) as compared to monounsaturated (MUFA) or polyunsaturated (PUFA) fatty acids appear particularly harmful as they increase both liver fat and insulin resistance. Overfeeding either saturated fat or carbohydrate increases liver fat content. Vitamin E supplementation decreases liver fat content as well as fibrosis but has no effect on features of insulin resistance. MDPI 2015-11-05 /pmc/articles/PMC4663582/ /pubmed/26556368 http://dx.doi.org/10.3390/nu7115454 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yki-Järvinen, Hannele
Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
title Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
title_full Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
title_fullStr Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
title_full_unstemmed Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
title_short Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
title_sort nutritional modulation of non-alcoholic fatty liver disease and insulin resistance
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663582/
https://www.ncbi.nlm.nih.gov/pubmed/26556368
http://dx.doi.org/10.3390/nu7115454
work_keys_str_mv AT ykijarvinenhannele nutritionalmodulationofnonalcoholicfattyliverdiseaseandinsulinresistance